Attenuating a sickle cell crisis with annexin V

Area of Science:

• Hematology
• Vascular Biology
• Biochemistry

Background:

• Sickle cell disease (SCD) involves painful crises that resolve spontaneously.
• An imbalance between steady state SCD and crisis state suggests potential therapeutic interventions.
• Prematurely senescent erythrocytes with exposed phosphatidylserine (PS) are implicated in SCD pathophysiology.

Purpose of the Study:

• To investigate the potential of Annexin V as a therapeutic agent to hasten the termination of sickle cell crises.
• To explore the role of phosphatidylserine (PS) exposure on erythrocytes in sickle cell crisis initiation and propagation.

Main Methods:

• The study focuses on the interaction of Annexin V with phosphatidylserine (PS) on senescent erythrocytes.
• Investigating how Annexin V binding to PS may inhibit erythrocyte adhesion and coagulation cascade initiation.

Main Results:

• In sickle cell disease (SCD), a high percentage of erythrocytes prematurely senesce and expose phosphatidylserine (PS).
• Exposed PS on circulating sickle erythrocytes promotes adhesion to the endothelium and initiates the coagulation cascade.
• Annexin V has a high affinity for PS, potentially shielding it and blocking these pathological processes.

Conclusions:

• Annexin V's ability to bind PS suggests it could act as a therapeutic shield.
• Targeting PS-exposing erythrocytes with Annexin V may offer a novel strategy to terminate sickle cell crises.
• This approach could help stabilize the physiologic balance disrupted during sickle cell crises.